These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7789877)

  • 1. Fertility therapy in the setting of a history of invasive epithelial ovarian cancer.
    Bandera CA; Cramer DW; Friedman AJ; Sheets EE
    Gynecol Oncol; 1995 Jul; 58(1):116-9. PubMed ID: 7789877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer associated with ovulation induction: a case report.
    Adewole IF; Babarinsa IA; Thomas JO; Ajayi AB
    Afr J Med Med Sci; 1997; 26(3-4):203-4. PubMed ID: 10456173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer and fertility medications: a critical appraisal.
    Kashyap S; Davis OK
    Semin Reprod Med; 2003 Feb; 21(1):65-71. PubMed ID: 12806561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors.
    Salomon LJ; Lhommé C; Pautier P; Duvillard P; Morice P
    Fertil Steril; 2006 May; 85(5):1510.e1-4. PubMed ID: 16647380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer after successful ovulation induction: a case report.
    Hull ME; Kriner M; Schneider E; Maiman M
    J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases of ovarian cancer after ovulation induction for infertility].
    Abboud J; Attieh E; Atallah D; Kessrouani A; Chaoul G
    Contracept Fertil Sex; 1997 Jan; 25(1):64-5. PubMed ID: 9064055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of ovarian cancer after treatment for infertility.
    Bristow RE; Karlan BY
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):32-7. PubMed ID: 8777256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
    Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of ovulation and ovarian cancer: a critical review of the literature.
    Mahdavi A; Pejovic T; Nezhat F
    Fertil Steril; 2006 Apr; 85(4):819-26. PubMed ID: 16580355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
    Azim AA; Costantini-Ferrando M; Oktay K
    J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative radiation therapy of symptomatic recurrent bladder cancer.
    Yi SK; Yoder M; Zaner K; Hirsch AE
    Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.